DOCS
Overvalued by 4.8% based on the discounted cash flow analysis.
Market cap | $9.78 Billion |
---|---|
Enterprise Value | $9.70 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $1.19 |
Beta | 1.41 |
Outstanding Shares | 188,362,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 43.96 |
---|---|
PEG | 81.76 |
Price to Sales | 17.84 |
Price to Book Ratio | 10.7 |
Enterprise Value to Revenue | 17.01 |
Enterprise Value to EBIT | 42.59 |
Enterprise Value to Net Income | 43 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.12 |
No data
No data
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinica...